Recall: D-0133-2025
Class II - Potentially Harmful
Class IIClassification
2024-11-19Initiated
OngoingStatus
Mylan Institutional, Inc.Firm
Product
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20
Reason
Subpotent and Superpotent Drug
Distribution
Nationwide in the USA.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.